Typicality: | 0.317 |
Saliency: | 0.059 |
in the encorafenib group | 4 | location |
grade → increase → arthralgia | 4 |
negative | neutral | positive |
0.636 | 0.349 | 0.016 |
Raw frequency | 4 |
Normalized frequency | 0.059 |
Modifier score | 0.900 |
Perplexity | 137.706 |